-
公开(公告)号:US11651847B2
公开(公告)日:2023-05-16
申请号:US16558698
申请日:2019-09-03
Inventor: Troy Long , Mingli Chen , Steve Jiang , Weiguo Lu
CPC classification number: G16H20/40 , A61N5/1031
Abstract: A method and system for generating a voxel-based quadratic penalty model for automatic intensity modulated radiation therapy (IMRT) treatment planning are disclosed herein. A computing system generates an initial assignment of threshold values to a penalty function for IMRT treatment planning. The computing system receives an update to a dose value associated with the IMRT treatment planning. The computing system dynamically updates the threshold values based on the updated dose value. The computing system continues to iterate the threshold values based on further updated dose values.
-
公开(公告)号:US11648209B2
公开(公告)日:2023-05-16
申请号:US17839699
申请日:2022-06-14
Inventor: Qiang Cheng , Tuo Wei , Daniel J. Siegwart
CPC classification number: A61K9/5123 , A61K48/0033 , C12N9/22 , C12N15/11 , C12N15/111 , C12N15/113 , C12N2310/11 , C12N2310/14 , C12N2310/20 , C12N2320/32
Abstract: The present disclosure provides compositions which shown preferential targeting or delivery of a nucleic acid composition to a particular organ. In some embodiments, the composition comprises a steroid or sterol, an ionizable cationic lipid, a phospholipid, a PEG lipid, and a permanently cationic lipid which may be used to deliver a nucleic acid.
-
公开(公告)号:US20230139593A1
公开(公告)日:2023-05-04
申请号:US17911346
申请日:2021-03-12
Inventor: Thomas Avery , Andrew Abell , Dion Turner , Peter M. Grace , Jiahe Li
IPC: A61K31/216 , A61K31/22 , A61K31/40 , A61K31/4409 , A61K31/341 , A61P25/02
Abstract: The present invention relates to the treatment of disorders associated with oxidative stress including neuropathic pain and small synthetically derived compounds for treating such disorders.
-
公开(公告)号:US11634699B2
公开(公告)日:2023-04-25
申请号:US17052116
申请日:2019-05-01
Applicant: The Regents of the University of California , The Board of Regents of The University of Texas System
Inventor: Robert T. Clubb , Brendan Rayhan Amer , Janine Y. Fu , Scott McConnell , Hung Ton-That , Chungyu Chang
Abstract: Covalently cross-linked pilus polymers displayed on the cell surface of Gram-positive bacteria are assembled by class C sortase enzymes. These pilus-specific transpeptidases located on the bacterial membrane catalyze a two-step protein ligation reaction—first, cleaving the LPXTG motif of one pilin protomer to form an acyl-enzyme intermediate, and second, joining the terminal threonine to the nucleophilic lysine residue residing within the pilin motif of another pilin protomer. Informed by the high-resolution crystal structures of corynebacterial pilus-specific sortase (SrtA) and by developing structural variants of the sortase enzyme whose catalytic pocket has been unmasked by activating mutations, we have developed new reagents capable of forming isopeptide bonds in vitro. The reagents disclosed herein can catalyze ligation of isolated SpaA domains in vitro provide a facile and versatile new platform for protein engineering and bio-conjugation that has major implications for biotechnology.
-
公开(公告)号:US11624050B2
公开(公告)日:2023-04-11
申请号:US17000235
申请日:2020-08-21
Inventor: Lingqian Chang , R. Lyle Hood , Forhad Akhter
Abstract: Disclosed is the design, fabrication, and characterization of a novel system comprising a parallel set of nanopore microneedles (NPMs) for cell transfection through controlled nanoelectroporation (NEP) and electrophoretic insertion of genetic materials.
-
公开(公告)号:US20230101768A1
公开(公告)日:2023-03-30
申请号:US17819620
申请日:2022-08-13
Applicant: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM , THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Inventor: Somshuvra Mukhopadhyay , Chunyi Liu , Donald Smith
IPC: A61K31/472 , A61K31/513 , A61K31/4704 , A61K31/437 , A61K31/5377 , A61K31/4418 , A61P3/12
Abstract: Disclosed is a method for treating manganese (manganese) toxicity in a subject. The method includes administering to the subject an effective amount of a hypoxia inducible factor (HIF) prolyl hydroxylase inhibitor or a pharmaceutically acceptable salt or solvate thereof.
-
公开(公告)号:US11615559B2
公开(公告)日:2023-03-28
申请号:US17498740
申请日:2021-10-11
Inventor: Karen Panetta , Long Bao , Sos Agaian
Abstract: The present disclosure includes systems and methods for color transfer. The method includes receiving a target image, and determining dominant source colors. The method further includes transforming the target image into a color model including a target luminance component and a target color information component. Additionally, the method includes segmenting the target image into a plurality of target segments based on the target color information component or the target luminance component and extracting dominant target colors from the target image by extracting information for at least one of the dominant target colors from each target segment of the plurality of target segments. Further, the method includes generating a color mapping relationship between the dominant target colors and the dominant source colors, and creating a recolored target image using the color mapping relationship.
-
公开(公告)号:US11599445B2
公开(公告)日:2023-03-07
申请号:US16442042
申请日:2019-06-14
Inventor: Tongping Liu , Hongyu Liu , Sam Albert Silvestro
Abstract: The techniques described herein may provide techniques for precise and fully-automatic on-site software failure diagnosis that overcomes issues of existing systems and general challenges of in-production software failure diagnosis. Embodiments of the present systems and methods may provide a tool capable of automatically pinpointing a fault propagation chain of program failures, with explicit symptoms. The combination of binary analysis, in-situ/identical replay, and debugging registers may be used together to simulate the debugging procedures of a programmer automatically. Overhead, privacy, transparency, convenience, and completeness challenges of in-production failure analysis are improved, making it suitable for deployment uses.
-
69.
公开(公告)号:US11590304B2
公开(公告)日:2023-02-28
申请号:US16325869
申请日:2017-08-15
Inventor: Craig Navarijo
Abstract: A resuscitation bag (bag valve mask resuscitator or BVM or BVMR) or other similar ventilation device (for example: anesthesia bag) includes a structure that allows a selectable, and repeatable volume be delivered to patients. The reservoir of the BVMR is formed from elastic, gastight material in the form of an elongated hollow body, with an essentially circular cross section. A range of motion control (ROMC) structure controls, or selectively limits the range of motion or collapse of the elastic bag to limit or control the volume expelled from the bag to the patient.
-
公开(公告)号:US11590085B2
公开(公告)日:2023-02-28
申请号:US17572615
申请日:2022-01-10
Inventor: Qiang Cheng , Tuo Wei , Daniel J. Siegwart
Abstract: The present disclosure provides compositions which shown preferential targeting or delivery of a nucleic acid composition to a particular organ. In some embodiments, the composition comprises a steroid or sterol, an ionizable cationic lipid, a phospholipid, a PEG lipid, and a permanently cationic lipid which may be used to deliver a nucleic acid.
-
-
-
-
-
-
-
-
-